Detection of synthetic glucocorticoids by liquid chromatography-tandem mass spectrometry in patients being investigated for Cushing's syndrome

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Clinical Biochemistry

• Publication date

  2011-08-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1258/acb.2011.010250PMID 21846739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cushing’s Syndrome

  2019cited by this paper
• Development of a liquid chromatography-tandem mass spectrometry with pressurized liquid extraction for determination of glucocorticoid residues in edible tissues.

  2011cited by this paper
• Improved liquid chromatography–tandem mass spectrometry method in clinical utility for the diagnosis of Cushing’s syndrome

  2010cited by this paper
• 11β-hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension

  2010cited by this paper
• The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension.

  2010cited by this paper
• Liquid chromatography-tandem mass spectrometry applications in endocrinology.

  2009cited by this paper
• Development of a rapid, multi-class method for the confirmatory analysis of anti-inflammatory drugs in bovine milk using liquid chromatography tandem mass spectrometry.

  2009cited by this paper
• 11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation.

  2009cited by this paper
• Evaluation of different scan methods for the urinary detection of corticosteroid metabolites by liquid chromatography tandem mass spectrometry.

  2009cited by this paper
• Inhaled corticosteroids for asthma: are they all the same?

  2009cited by this paper
• A screening method for the detection of synthetic glucocorticosteroids in human urine by liquid chromatography–mass spectrometry based on class-characteristic fragmentation pathways

  2008cited by this paper
• Optimization of solid phase extraction clean up and validation of quantitative determination of corticosteroids in urine by liquid chromatography-tandem mass spectrometry.

  2008cited by this paper
• Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays

  2008cited by this paper
• The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

  2008cited by this paper
• Simultaneous quantitation of dexamethasone palmitate and dexamethasone in human plasma by liquid chromatography/tandem mass spectrometry.

  2008cited by this paper
• Rapid multi-residue method for the quantitative determination and confirmation of glucocorticosteroids in bovine milk using liquid chromatography-electrospray ionization-tandem mass spectrometry.

  2007cited by this paper
• Simultaneous measurements of urinary free cortisol and cortisone for the assessment of functional glucocorticoid activity.

  2007cited by this paper
• Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry.

  2007cited by this paper
• Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma

  2006cited by this paper
• A fast liquid chromatographic/mass spectrometric screening method for the simultaneous detection of synthetic glucocorticoids, some stimulants, anti-oestrogen drugs and synthetic anabolic steroids.

  2006cited by this paper
• Hypertension in Cushing's syndrome.

  2006cited by this paper
• Measurement of urinary free cortisol using liquid chromatography-tandem mass spectrometry: comparison with the urine adapted ACS:180 serum cortisol chemiluminescent immunoassay and development of a new reference range

  2005cited by this paper
• Quantification of betamethasone in human plasma by liquid chromatography-tandem mass spectrometry using atmospheric pressure photoionization in negative mode.

  2005cited by this paper
• Assessing analytical specificity in quantitative analysis using tandem mass spectrometry.

  2005cited by this paper
• Resolution, quantification and confirmation of betamethasone and dexamethasone in equine plasma by liquid chromatography/tandem mass spectrometry.

  2005cited by this paper
• Prednisolone measurement in human serum using liquid chromatography tandem mass spectrometry

  2005cited by this paper
• Exogenous Cushing's syndrome and glucocorticoid withdrawal.

  2005cited by this paper
• Analysis of betamethasone, dexamethasone and related compounds by liquid chromatography/electrospray mass spectrometry.

  2004cited by this paper
• Risk‐Benefit Value of Inhaled Glucocorticoids: A Pharmacokinetic/ Pharmacodynamic Perspective

  2004cited by this paper
• Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids.

  2004cited by this paper
• Determination of urinary free cortisol by liquid chromatography‐tandem mass spectrometry

  2003cited by this paper
• Liquid chromatography-tandem mass spectrometry analysis of urinary free cortisol.

  2003cited by this paper
• Differentiation of betamethasone and dexamethasone using liquid chromatography/positive electrospray tandem mass spectrometry and multivariate statistical analysis.

  2002cited by this paper
• Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone.

  2002cited by this paper
• Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide

  2002cited by this paper
• Accelerated solvent extraction and liquid chromatography-tandem mass spectrometry quantitation of corticosteroid residues in bovine liver.

  2001cited by this paper
• Cushing's syndrome.

  2001cited by this paper
• Differentiation between dexamethasone and betamethasone in a mixture using multiple mass spectrometry.

  2001cited by this paper
• Collision-induced dissociation of corticosteroids in electrospray tandem mass spectrometry and development of a screening method by high performance liquid chromatography/tandem mass spectrometry.

  2000cited by this paper
• Identification of main corticosteroids as illegal feed additives in milk replacers by liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry.

  1998cited by this paper
• Clinical relevance of inhaled corticosteroids and HPA axis suppression.

  1998cited by this paper
• Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome.

  1997cited by this paper
• Cushing's Syndrome

  1944cited by this paper

• Metabolomics studies in cushing’s syndrome: recent developments and perspectives

  2025cites this paper
• Current Challenges and Future Directions in the Assessment of Glucocorticoid Status

  2024cites this paper
• Cortisol: Analytical and clinical determinants.

  2023cites this paper
• Simultaneous Measurement of Cortisol, Cortisone, Dexamethasone and Additional Exogenous Corticosteroids by Rapid and Sensitive LC–MS/MS Analysis

  2022cites this paper
• Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?

  2020cites this paper
• Analytical Strategies for the Detection of Anti-Inflammatory Drugs in Cartilage and Bone Health Supplements

  2020cites this paper
• Cushing Disease: Diagnosis and Treatment

  2019cites this paper
• The evolution of methods for urinary steroid metabolomics in clinical investigations particularly in childhood.

  2018cites this paper
• Principles, current applications, and future perspectives of liquid chromatography-mass spectrometry in clinical chemistry

  2017cites this paper
• In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry.

  2017cites this paper
• Measuring cortisol in serum, urine and saliva – are our assays good enough?

  2017cites this paper
• Urinary proteomics and metabolomics in the diagnosis of pediatric disorders

  2015cites this paper
• La diagnostica di laboratorio delle malattie del surrene. Raccomandazioni pratiche per la sindrome di Cushing

  2015cites this paper
• The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome: the use of a LC-MS/MS method in routine clinical practice.

  2014cites this paper
• Managing Cushing’s disease: the state of the art

  2014cites this paper
• Development and Validation of a Simple Liquid Chromatography Method for the Quantification of Degradation Products of Beclomethasone Dipropionate from a Respirator Suspension Formulation

  2014cites this paper
• LC–MS/MS in the routine clinical laboratory: has its time come?

  2014cites this paper
• The use of mass spectrometry to improve the diagnosis and the management of the HPA axis

  2013cites this paper